Search

Author/Creator Grund, B

2. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. (April 2015)

Authors:
Carr, A; Grund, B; Neuhaus, J; Schwartz, A; Bernardino, JI; White, D; Badel‐Faesen, S; Avihingsanon, A; Ensrud, K; Hoy, J
Journal:
HIV medicine
Issue:
Volume 16(2015)Supplement 1
Page Start:
137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy. Issue 1 (23rd October 2019)

Authors:
Carr, A; Grund, B; Schwartz, AV; Avihingsanon, A; Badal‐Faesen, S; Bernadino, JI; Estrada, V; La Rosa, A; Mallon, PWG; Pujari, S; White, D; Wyman Engen, N; Ensrud, K; Hoy, JF
Journal:
HIV medicine
Issue:
Volume 21:Issue 1(2020)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search